Nello Mainolfi - 07 Jul 2026 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: KYMR
Reported as of: 07 Jul 2026
Net transaction value: -$5,950,000
SEC form: 4
Accepted by SEC: 07 Jul 2026, 20:00:03 UTC
Prior SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Bruce Jacobs, as Attorney-in-Fact

Key filing fact

Nello Mainolfi filed Form 4 for Kymera Therapeutics, Inc. (KYMR) on 07 Jul 2026.

Key facts

This page summarizes Nello Mainolfi's Form 4 filing for Kymera Therapeutics, Inc. (KYMR).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 07 Jul 2026, 20:00.

Change

Previous filing in this sequence was filed on 02 Jul 2026.
Current net transaction value: -$5,950,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001821189 Primary reporting owner

Mainolfi Nello

Relationship: Chief Executive Officer, Director
Address: C/O KYMERA THERAPEUTICS, INC., 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN
Signature: /s/ Bruce Jacobs, as Attorney-in-Fact
Signature date: 07 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KYMR transaction

Common Stock

Options Exercise

Transaction value
Shares: +50,000
Change %: +7.5%
Price: $2.08^*
Shares after: 716,568
Date: 07 Jul 2026
Ownership: Direct
Footnotes: F1

KYMR transaction

Common Stock

Sale

Transaction value: $5,950,000
Shares: -50,000
Change %: -7%
Price: $119.00
Shares after: 666,568
Date: 07 Jul 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KYMR transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -45,559
Change %: -34%
Price: $0.000000^*
Shares after: 90,000
Date: 07 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 45,559
Exercise price: $2.08
Footnotes: F1, F2

KYMR transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -4,441
Change %: -24%
Price: $0.000000^*
Shares after: 14,284
Date: 07 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,441
Exercise price: $2.08
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.

Footnote F2

The shares underlying this stock option are fully vested and exercisable.